China is the fourth major market where Kisunla has been approved after the US, Japan, and GB. It gets the green light there ...

Minnesota Alzheimer's patients will be among the first to receive a new treatment through the drug Kisunla, which targets the ...

Eli Lilly (LLY) stock in focus as China approves its Alzheimer's treatment Kisunla (donanemab). Read more here.

FOX 9 caught up with a Minnesota woman undergoing a new Alzheimer’s treatment which is showing promise in slowing cognitive ...

China's medical regulator has approved Eli Lilly's treatment for early Alzheimer's, providing patients with another option ...

Kathy Ingebrand of Mahtomedi is one of the first people in the country to receive the infusion meant to slow down Alzheimer's disease by up to 35%.

The summary highlights significant activities in the health sector, including Eli Lilly's Alzheimer's treatment approval in ...

What Eli Lilly (NYSE: LLY) is doing is far more impressive. While many investors may buy it for its growth potential, here's ...

Eli Lilly and EVA Pharma have announced approval from the Egyptian Drug Authority for the human insulin glargine injection.

- USD/JPY: Implied 1-day volatility rises to 21.75 ahead of Fed and BOJ decisions – US financial press [Dec 12th: USD/JPY 1-week implied volatility rises to ~11.7 (BOJ decision is on Dec 19th) – US ...

Recent health developments include Eli Lilly's Alzheimer's treatment approval in China, a DOJ lawsuit against CVS for opioid ...